Genomic alteration profile and <scp>PD‐L1</scp> expression among different breast cancer subtypes in Chinese population and their correlations-Reference-Cited by-同舟云学术

Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations

Published:2022-11-20 Issue:5 Volume:12 Page:5195-5208
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Li Kai¹,Cao Li¹,Li Cheukfai¹^ORCID,Wu Jundong²,Chen Bo¹,Zhang Guochun¹,Li Xueri¹,Wen Lingzhu¹,Jia Minghan¹,Wei Guangnan¹³,Lin Jiali¹⁴,Li Yingzi¹,Zhang Yuchen¹,Mok Hsiaopei¹,Ren Chongyang¹,Wang Yulei¹,Qi Xiaofang⁵,Guo Lijie⁵^ORCID,Che Yue⁵,Liao Ning¹^ORCID

Affiliation:

1. Department of Breast Cancer, Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou China

2. Guangdong Provincial Key Laboratory for Breast Cancer Diagnosis and Treatment Cancer Hospital of Shantou University Medical College Shantou China

3. School of Medicine South China University of Technology Guangzhou China

4. The Second School of Clinical Medicine Southern Medical University Guangzhou China

5. OrigiMed Shanghai China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5314

Reference36 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Current Landscape of Immunotherapy in Breast Cancer

3. PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences Are Emerging. A Literature Review

4. Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

5. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study